Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03778385
Other study ID # HR-3035
Secondary ID R15HD090265TL1TR
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 3, 2017
Est. completion date January 2023

Study information

Verified date June 2022
Source Marquette University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the influence different types of exercise, pain mechanisms, and biopsychosocial contributions on how people with and without fibromyalgia report pain. Exercise will be performed with the arm at a submaximal intensity. Participants will undergo a variety of pain assessments, including clinical questionnaires and pain perception. This study will improve our understanding of how people with and without fibromyalgia respond to different resistance exercise types and whether physical activity and body composition has an influence on the response.


Description:

Fibromyalgia is a chronic widespread pain condition that is mostly prevalent in middle-aged women. Exercise is one of the few therapies that can alleviate fibromyalgia symptoms. Despite exercise being a major component of rehabilitation, exercise guidelines are unclear, often leading to symptom exacerbation and low compliance. Previous research has demonstrated that women with fibromyalgia may have different post-exercise pain responses when undergoing an exercise task. Factors critical to optimal exercise prescription are not known, including the most effective type of exercise, mechanisms responsible for pain relief, and biopsychosocial influences. This study investigates the use of exercise as a nonpharmacological pain management tool for people with fibromyalgia. The purpose of this study is to investigate the acute exercise-induced pain response after isometric and dynamic muscle contractions in people with and without fibromyalgia. All participants will attend up to three sessions with approximately one week between sessions at a metropolitan university laboratory setting. Participants will perform different types of submaximal exercise for a maximum of ten minutes and complete pain assessments each session. Pain and psychosocial influences are measured with multiple established clinical questionnaires. Pressure pain sensitivity is tested by application of a mechanical stimulus to the arms and legs. To investigate a participant's innate ability to inhibit pain, the mechanical stimulus will be assessed with and without limb submersion in a cold-water bath. Physical activity is measured via questionnaire and use of activity monitors, while body composition is measured with a dual energy x-ray absorptiometry scan.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 99
Est. completion date January 2023
Est. primary completion date January 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Fibromyalgia - Healthy Controls without fibromyalgia - Stable medical management plan for four weeks prior to participation in the study. - Physical Activity Readiness Questionnaire (PAR-Q) - English proficiency Exclusion Criteria: - Elbow arthritis - Carpal tunnel syndrome - Cervical surgery - Cerebrovascular accident / stroke - Multiple sclerosis - Parkinson's disease - Any central neurodegenerative disease - Traumatic brain injury - Peripheral neuropathy of the upper extremity - Myocardial infarction - Chronic obstructive pulmonary disease - Any unstable medical or psychiatric condition - Diabetes mellitus - Active cancer - Lymphedema of the upper extremity - Claustrophobia - Raynaud's phenomenon - Osteoporosis - Major depressive disorder - Bipolar disorder - Rheumatoid arthritis - Lupus - Polymyalgia rheumatica - Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exercise
Submaximal exercise is performed in randomized order with the participant seated and the arm supported in an adjustable hand-arm orthosis.

Locations

Country Name City State
United States Marquette University Milwaukee Wisconsin

Sponsors (3)

Lead Sponsor Collaborator
Marquette University Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Center for Advancing Translational Science (NCATS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline Short-Form McGill Pain Questionnaire to 7-days after performance of exercise. The Short-Form McGill Pain Questionnaire is a multi-dimensional tool to assess pain quality in chronic pain patients. Participants rate the intensity of pain and related symptoms they felt during the past week on 0 to 3 scale, with 0 being no pain and 3 being severe. The total score ranges from a minimum of 0 to maximum 45 with higher scores indicating worse symptoms. Before and up to 7-days after performance of exercise.
Primary Change from Baseline Fibromyalgia Impact Questionnaire to 7-days after performance of exercise. The Fibromyalgia Impact Questionnaire - Revised measures function, overall impact, and symptoms of fibromyalgia. Participants rate the difficulty in performing daily tasks, the impact of their symptoms, and intensity of fibromyalgia symptoms on a 0 to 10 scale, with 10 signifying greater significance. The total score ranges from a minimum of 0 to maximum of 210 with higher scores indicating worse function and symptoms. Before and up to 7-days after performance of exercise.
Primary Change from Baseline Pain Rating from a Pressure Pain Device to immediately after performance of exercise. Application of mechanical stimulus through a weighted Lucite edge will be applied to the finger for a maximal duration of 2 minutes. Subjects will provide a pain rating every 20 seconds during the 2-minute test. Pain ratings are provided with use of a Numerical Pain Rating Scale that ranges from 0 (no pain) to 10 (worst pain). Before and immediately after performance of exercise.
Primary Change from Baseline Pressure Pain Threshold to immediately after performance of exercise. Application of a pressure stimulus is applied to the bicep muscle and quadriceps muscle at a rate of 50kPa per second until the pressure first becomes painful. Before and immediately after exercise.
Primary Change from Baseline Numerical Pain Rating Scale to 7-days after performance of exercise. Pain in the exercising limb and whole body will be reported. Pain ratings are provided with use of a Numerical Pain Rating Scale that ranges from 0 (no pain) to 10 (worst pain). Before, during, and up to 7-days after performance of exercise.
Primary Change in Pain Catastrophizing before to after exercise. Measures the exaggerated negative mental set brought to bear during an actual or anticipated painful experience. Measured with the Pain Catastrophizing Scale which has subscales of rumination, magnification, and helplessness. Rumination scale ranges from 0 to 16 with higher score indicating higher levels of rumination. Magnification scale ranges from 0 to 12 with higher scores indicating higher levels of magnification. Helplessness scale ranges from 0 to 24 with higher scores indicating higher levels of helplessness. The subscale scores are summed to compute a total score ranging from 0 to 52 with higher scores indicating higher levels of pain catastrophizing. Through study completion, an average of 3 weeks.
Primary Baseline Tampa Scale of Kinesiophobia - 11 Measures pain-related fear in relation to movement or avoidance type behaviors. A total score is computed ranging from 0 to 44 with higher scores indicating higher levels of pain-related fear. At the beginning of each session.
Primary Change from Baseline PROMIS Short Form v1.0 - Fatigue 7a at completion of study. Measures the experience and impact of fatigue on daily activity. The PROMIS Short Form v1.0 - Fatigue 7a measures subjective feelings of tiredness to a sense of exhaustion that likely decreases one's ability to execute daily activities and function normally in family or social roles. Participants rank the level of tiredness on a scale of 1 (never) to 5 (always). The total score ranges from 7 to 35 with 35 indicating greater levels of exhaustion that impacts ability to perform daily tasks. At the beginning of each exercise session.
Primary American College of Rheumatology Diagnostic Criteria for Fibromyalgia Questionnaire characterizing the symptoms of those with fibromyalgia. The scale is composed of 3 subscales; widespread pain index, symptom severity score A and B. The widespread pain index ranges from 0 to 19 with 19 indicating greater number of body areas in which pain was experienced. The symptom severity score A ranges from 0 to 9 with 9 indicating greater symptom severity. The symptom severity score B ranges from 0 to 3 with 3 indicating greater number of symptoms experienced. The total Symptom Severity Score is calculated by adding symptom severity score A and symptom severity score B with a total range of 0 (no symptoms) to 12 (great deal of symptoms). At the beginning of each session.
Primary Conditioned Pain Modulation The difference in pressure pain (measured via pressure algometry) at the biceps and quadriceps with and without the subject's limb placed in an ice water bath. Day 1 of enrollment
Primary Physical Activity Assessment Tool The Physical Activity Assessment Tool estimates the amount of physical activity performed and perceptions towards participation in physical activity. The total amount of time per day (minutes/day) is calculated for time spent in moderate to vigorous physical activity. With 0 minutes indicating no time spent in moderate to vigorous physical activity and higher values indicating greater time spent in moderate to vigorous physical activity. Up to 7 days.
Primary Total time spent in sedentary and moderate to vigorous physical activity measured by an Actigraph wGT3x over the course of 7 days. An Actigraph wGT3x is a wrist worn device that is used to track the amount and intensity of physical activity performed over the course of seven days. Total time spent in sedentary and moderate to vigorous physical activity is measured in minutes. Worn continuously for a 7-day period during study enrollment.
Primary Baseline Lean Mass Measurement of lean mass with use of dual energy x-ray absorptiometry testing. 7 to 14 days after enrollment.
Primary Baseline Fat Mass Measurement of fat mass with use of dual energy x-ray absorptiometry testing. 7 to 14 days after enrollment.
Secondary Change from Baseline Maximal Voluntary Force to immediately after performance of exercise. Maximal force produced with the arm when performing a bending motion of the elbow. Maximal torque is measured with an isokinetic dynamometer with higher levels indicating greater amount of force. Before and immediately after performance of exercise.
Secondary Baseline voluntary muscle activation of the biceps muscle Assess each subject's ability to voluntarily activate their bicep muscle when performing a maximal voluntary contraction of the elbow flexors. Participants will generate maximal force from their elbow flexors with application of muscle stimulation. Muscle stimulation is provided via electrodes placed on the skin overlying the biceps muscle and activation of the muscle will be achieved by a constant-current stimulator. Force is recorded via isokinetic dynamometry. To assess voluntary activation, a single twitch will be interpolated during the plateau of the maximal voluntary contraction force by the stimulator. Through study completion, an average of 3 weeks.
Secondary Change from Baseline Heart Rate to immediately after performance of exercise. Heart rate is measured with an automated cuff applied to the wrist. Measured before, during, and immediately after exercise.
Secondary Change from Baseline Blood Pressure to immediately after performance of exercise. Blood pressure is measured with an automated cuff applied to the wrist. Measured before, during, and immediately after exercise.
Secondary Change from Baseline Rating of Perceived Exertion to immediately after performance of exercise Rating of Perceived Exertion refers to the total amount of exertion a participant is feeling and measured with a modified BORG scale ranging from 0 (nothing) to 10 (maximal exertion). Measured before, during, and immediately after exercise.
Secondary Baseline sensory threshold assessed with von Frey monofilaments Monofilaments will be applied perpendicular to the skin in ascending order, the lowest-size filament to induce sensation is recorded. At the beginning of each session.
Secondary Change from baseline pain unpleasantness up to 7 days after exercise. Unpleasantness in the exercising limb will be reported with a 0-10 numerical rating scale. Before, during, and up to 7-days after performance of exercise.
Secondary Change from baseline PROMIS Short Form v1.0 Pain Interference 6b up to 7 days after exercise. A 6-item questionnaire will help measure interference of pain on functional daily activity. Before, during, and up to 7-days after performance of exercise.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05659862 - Digitally Assisted Behavioral Physical Activity Intervention in Fibromyalgia N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT03042728 - Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program N/A
Recruiting NCT06097091 - Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia N/A
Recruiting NCT04554784 - Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia N/A
Completed NCT03300635 - Metabolism, Muscle Function and Psychological Factors in Fibromyalgia N/A
Recruiting NCT06166563 - Exercise, Irritable Bowel Syndrome and Fibromyalgia N/A
Completed NCT03166995 - Postural Exercises in Women With Fibromyalgia N/A
Completed NCT03227952 - Sensory Stimulation in Fibromyalgia N/A
Recruiting NCT06237595 - Vagus Nerve Stimulation in Fibromyalgia N/A
Completed NCT01888640 - Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST) N/A
Completed NCT03641495 - Pain Education and Therapeutic Exercise for Fibromyalgia N/A
Recruiting NCT05581628 - FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
Active, not recruiting NCT05128162 - Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia Phase 2
Completed NCT04674878 - Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia N/A
Active, not recruiting NCT04084795 - Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia N/A
Completed NCT03129906 - Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients N/A
Completed NCT05058911 - Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia N/A
Recruiting NCT04571528 - Effectiveness of VIRTUAL FIBROWALK STUDY N/A
Recruiting NCT04571853 - New Educational Tool for FM N/A